CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent form of skin cancer, showing a rapid increasing incidence worldwide. Although most cSCC can be cured by surgery, a sizeable number of cases are diagnosed at advanced stages, with local invasion and distant metastatic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Quadri, Marika, Tiso, Natascia, Musmeci, Francesco, Morasso, Maria I., Brooks, Stephen R., Bonetti, Luca Reggiani, Panini, Rossana, Lotti, Roberta, Marconi, Alessandra, Pincelli, Carlo, Palazzo, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339543/
https://www.ncbi.nlm.nih.gov/pubmed/37443031
http://dx.doi.org/10.1186/s13046-023-02737-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339543/
https://www.ncbi.nlm.nih.gov/pubmed/37443031
http://dx.doi.org/10.1186/s13046-023-02737-7

Ejemplares similares